19.06.2013
- When trying to assess changes within the chemical distribution market, one can outline and distinguish three central issues: business setup, adaptability and regional structure...
19.06.2013
- Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping research and boosting acquisitions set to take up to four years to pay off, its chief...
19.06.2013
- Total said it will invest €1 billion in modernizing its Antwerp production complex, the group's largest refining and petrochemical platform in Europe. The company said the decision...
19.06.2013
- U.S.-based Royalty Pharma has dropped a hostile bid worth up to $8 billion for Elan, leaving the Irish drugmaker free to seek other suitors having put itself up for sale last week...
18.06.2013
- Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster J&J's role in the field after it acquired...
18.06.2013
- ViroPharma is attracting preliminary interest from several pharmaceutical companies about buying the orphan drugmaker, according to three people familiar with the matter. While...
18.06.2013
- Spanish PET producer La Seda de Barcelona has filed an insolvency petition in a Barcelona commercial court after failing to gain the support of 75% of its creditors to restructure...
18.06.2013
- Gases and engineering group Linde has signed a contract with Russian petrochemical giant Sibur to manage the gas supply infrastructure at Sibur's Dzerzhinsk site in the Nizhny...
18.06.2013
- At the G8 summit in Northern Ireland, the United States and the European Union agreed to begin negotiations on a broad bilateral trade agreement. The Transatlantic Trade and...
18.06.2013
- Elan shareholders approved a share buyback on Monday, meaning U.S.-based Royalty Pharma's hostile bid for the Irish drug firm will lapse unless it succeeds in a legal challenge...
